The expression of IL1B in tumor tissue is more closely related to the prognosis of HNSCC, while serum IL1B is also altered by non-tumor inflammatory diseases, such as periodontitis, arthritis, and enteritis, among others. Here, IL1B is linked to arthritic joint disease.